Table 1.

Susceptibility of Candida albicans clinical isolates to F105 and conventional antimycotics.

Isolate/Strain	Source	MIC (μg/mL)
		F105	Fluconazole	Terbinafine	Nystatin
NCTC®885-653	NCTC Collection	64	64	8	8
K3836-19	Phlegm	64	32	4	4
K4026-19	Buccal swab	32	8	2	8
K4085-19	Buccal swab	256	16	4	4
K4146-19	Buccal swab	256	16	4	8
K46-19	Buccal swab	>256	128	8	8
K47-19	Buccal swab	256	64	32	16
K4940-19	Buccal swab	64	128	16	8
K4941-19	Buccal swab	>256	64	8	8
K4956-19	Buccal swab	>256	>128	16	4
K4978-19	Buccal swab	64	32	8	2
K5002-19	Cervical canal	>256	128	16	8
K5007-19	Buccal swab	64	>128	16	4
K5012-19	Buccal swab	64	64	32	8
K5014-19	Buccal swab	64	16	16	8
K5030-19	Buccal swab	32	128	16	8
K5038-19	Urethral mucosa	>256	32	8	16
K5050-19	Buccal swab	256	64	8	2
K5061-19	Buccal swab	128	32	16	4
K5077-19	Buccal swab	128	64	16	4
K5081-19	Buccal swab	128	64	32	4
K5092-19	Buccal swab	256	128	16	8
K5094-19	Buccal swab	>256	64	16	8
K5096-19	Buccal swab	32	64	16	2
K5097-19	Buccal swab	256	64	16	4
K625-19	Vaginal swab	256	32	4	4
K6631-19	Throat swab	>256	32	4	2

*The above data are medians calculated from a series of six independent measurements.